Veterinary Infectious Diseases Diagnostics Market - Forecasts from 2025 to 2030

The Global Veterinary Infectious Diseases Diagnostics Market is expected to grow from USD 2.795 billion in 2025 to USD 4.124 billion in 2030, at a CAGR of 8.09%.

Rising Prevalence of Infectious Diseases

The growing incidence of infectious diseases in both companion and livestock animals is a primary driver of market expansion. Zoonotic diseases, including rabies, which causes tens of thousands of deaths annually (with 99% of human cases linked to dogs, per WHO), and canine distemper, are increasing due to bacterial, viral, and parasitic infections exacerbated by poor hygiene practices in animal environments. For instance, rabies, prevalent in over 150 countries, imposes an economic burden of approximately US$8.6 billion annually, with significant impacts in Asia and Africa. Livestock animals face high disease susceptibility, with one in five farm animals lost to serious infections, leading to global economic losses of around US$80 billion. This underscores the critical need for regular diagnostic checkups to ensure animal health and prevent disease transmission, particularly for zoonotic diseases that pose public health risks. The urgency for early detection is further amplified by diseases like avian influenza, with over 3,500 outbreaks reported globally in 2023, highlighting the need for robust diagnostics.

Growing Demand for Livestock Health

Livestock animals are vital for food security, nutrition, and economic growth, yet infectious diseases threaten their productivity and the quality of animal-derived products like meat, poultry, and dairy. Unhygienic conditions, such as contaminated water sources and feed, foster the growth of bacteria and parasites, increasing disease prevalence. This drives demand for veterinary diagnostics to mitigate risks and ensure the health of livestock, which is critical for sustaining agricultural economies and meeting global food demands.

Technological Advancements

Advancements in diagnostic technologies are transforming the market by enabling faster, more accurate disease detection. In September 2024, Zoetis launched Vetscan OptiCell, an AI-powered, cartridge-based hematology analyzer for point-of-care complete blood count (CBC) analysis, offering lab-quality results with enhanced efficiency. Additionally, Zoetis introduced the Stablelab handheld device, a point-of-care blood test that detects equine inflammation via Serum Amyloid A (SAA) levels within 10 minutes, allowing veterinarians to identify infections before symptoms appear. Prosolit’s ELISA kit for serodiagnosis of Bovine Adenovirus 3 provides rapid, reliable testing for cattle, targeting blood sera, plasma, and milk, enhancing diagnostic accuracy for livestock. In February 2024, MiDOG Animal Diagnostics introduced an All-in-One Diagnostic Test for rapid detection of bacterial and fungal infections, including antibiotic resistance, across various animal species, replacing traditional methods with molecular-based diagnostics. These innovations reflect a trend toward point-of-care and molecular diagnostics, improving treatment outcomes and driving market growth.

Market Segmentation Analysis

Molecular Diagnostics

The molecular diagnostics segment is poised for significant growth due to its high sensitivity, rapid results, and increasing adoption in research centers and diagnostic laboratories. Techniques like real-time PCR and multiplex PCR, as seen in products like Zoetis’ VetScan Flex4, enable precise detection of genomic variants for infectious diseases, genetic disorders, and therapy monitoring. The complexity and rising prevalence of diseases in livestock and companion animals are encouraging owners to opt for these advanced tests, boosting their market share over the forecast period.

Livestock Animals

The livestock segment is expected to hold a notable market share, driven by the high disease burden and economic implications of infections. The need for routine diagnostics to monitor diseases like bovine tuberculosis, swine fever, and avian influenza is critical for maintaining herd health and ensuring food safety. For instance, regular mastitis screening in dairy cattle, supported by Zoetis’ Vetscan Mastigram+ launched in August 2023, enhances milk quality and herd productivity. The segment’s growth is further fueled by government initiatives, such as India’s development of Bluetongue Sandwich ELISA and Japanese Encephalitis IgM ELISA kits under the “Make in India” program in 2023.

Regional Insights

North America dominates the market with a 38% share in 2024, driven by advanced veterinary infrastructure, high pet ownership (94 million U.S. households with pets in 2025), and significant health expenditure. The Asia-Pacific region is the fastest-growing, propelled by rising zoonotic disease awareness, increasing pet adoption, and government support for animal health, particularly in countries like India and China.

Market Challenges

Challenges include the high cost of advanced diagnostic tests and a shortage of skilled veterinarians in emerging markets, which may limit adoption. Additionally, ensuring hygiene in livestock environments remains a hurdle, as poor conditions exacerbate disease spread, necessitating ongoing investment in diagnostics and infrastructure.

Conclusion

The veterinary infectious disease diagnostics market is set for robust growth through 2028, driven by rising disease prevalence, particularly zoonotic and livestock infections, and advancements in molecular and point-of-care diagnostics. Innovations from key players like Zoetis and Prosolit, alongside growing demand for livestock health management, are key catalysts. North America and Asia-Pacific lead regional growth, though challenges like cost and skill shortages require strategic solutions to sustain market momentum.

Key Benefits of this Report:

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

• Historical data from 2022 to 2024 & forecast data from 2025 to 2030
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries
• Company Profiling (Strategies, Products, Financial Information, and Key Developments among others).

Segmentation:

By Technology Type

• Immunodiagnostics
• Molecular Diagnostics
• Hematology
• Urinalysis
• Others

ByPathogenType

• Virus
• Bacteria
• Parasite
• Others

By Animal Type

• Companion Animal
• Cats
• Dogs
• Horse
• Others
• Livestock
• Cattle
• Swine
• Sheep
• Others

By End-User

• Diagnostics Laboratories
• Veterinary Clinics
• Research Centers

By Geography

• North America
• USA
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• UK
• Germany
• France
• Spain
• Others
• Middle East and Africa
• Saudi Arabia
• UAE
• Israel
• Others
• Asia Pacific
• Japan
• China
• India
• South Korea
• Others